Regulatory update: albiglutide US PDUFA date extended by three months
Issued: Friday 2August 2013, London UK GlaxoSmithKline plc (LSE:GSK) today announced that the US Prescription Drug User Fee Act (PDUFA) goal date for albiglutide, an investigational once-weekly treatment for adult patients with type 2 diabetes, has been …